The authors demonstrated in nasopharynx carcinoma and lung carcinoma cell lines that HELLS stabilizes P53 post-transcriptionally by preventing it from proteasomal degradation and promoting its phosphorylation to orchestrate cancer cell lipid metabolism. This evidence concerns the gene TP53 and nasopharyngeal carcinoma.